Should You Buy Shares of This Top CBD Company After Earnings?

Charlotte’s Web Holdings Inc (TSX:CWEB) holds the largest share of the U.S. CBD market. Here is why the firm’s stock is worth considering.

| More on:

With the passage of the Farm Bill in the U.S. at the end of last year, companies that focus on the hemp-based CBD market are experiencing strong sales and revenue growth. The future of this industry is bright, and Charlotte’s Web Holdings (TSX:CWEB) is arguably better positioned than any of its peers to profit from it. The Colorado-based firm recently released its Q2 2019 financial results. Let’s see how the pot company performed during the second quarter. 

Top line keeps growing 

Charlotte’s Web was able to ramp its production capacity to new levels this year thanks to less restrictive laws. The firm’s hemp acreage increased by 187% compared to 2018. This helped the company deliver strong revenue growth. CWEB posted a 45% year-over-year organic top-line growth. The company’s gross margin of 75% — resulting in a gross profit of $18.8 million — is also commendable. Finally, unlike many of its peers in the industry, CWEB has been consistently profitable for a while. During the second quarter, the company posted net earnings of $2.2 million, though that represents a 40% decrease year over year. 

Investing for the future

Charlotte’s Web spent a lot of funds to increase its production capacity. This move came as a growing number of brick-and-mortar stores are carrying its products. CWEB’s products can be found in over 8,000 retail stores in the U.S., including such major retailers as CVS Health. It isn’t surprising that the company would spend the money necessary to keep up with this increasing retail presence.

Further, CWEB expects the demand for CBD-based products to continue on an upward trajectory. After all, the entire cannabis industry is growing, and the CBD market is especially appealing to both recreational and medical users. CWEB is also diversifying its product offerings. During the second quarter, the company introduced CBD-based gummies and a line of products for pets — the latter of which is already making the rounds.

The company secured two distribution partners for its products for pets. One of them is Pacific Pet, a California-based pet food store with a significant presence in the west coast. The other is Pet Food Experts, a store with a significant retail presence in about a handful of states.

Deanie Elner, Charlotte’s Web newly appointed CEO, said the following: “We are experiencing increased momentum with large retailers as consumer awareness and interest in CBD grows. We believe we’ll continue to see additional large retailers coming on board and expect an increase in the number of states and locations with our existing retail partners throughout the year. Kroger is the most recent example as they added four new states to their distribution in July, including Texas, which is the latest state to approve hemp CBD products.”

The bottom line

If the demand for CBD product continues to grow, as CWEB is anticipating, the firm will likely remain one of the leaders in the market. With an increasing presence across U.S. states and a growing portfolio of products, Charlotte’s Web might be one of the top companies to invest in to profit from the soaring CBD market. 

Fool contributor Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »